|Articles|August 1, 2011
- BioPharm International-08-01-2011
- Volume 24
- Issue 8
BioPharm International, August 2011 Issue (PDF)
Top 1000 Biomanufacturing Facilities
Advertisement
Articles in this issue
over 14 years ago
Efficient Multiproduct Process Development Case Studyover 14 years ago
Offshoring Biomanufacturingover 14 years ago
Particulate Quality of Single-Use Filling Systemsover 14 years ago
Developing an International Dialogue on Biologics Standardsover 14 years ago
FDA Maps Strategy to Counter Supply-Chain Threatsover 14 years ago
Biopharmaceutical High Performanceover 14 years ago
Biosimilars or Bustover 14 years ago
Top 1000 Global Biomanufacturing FacilitiesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Experts Probe CNPV Impacts: Part II
2
How New ADC Modalities Backed by Samsung Could Shape Solid Tumor Treatment
3
What a $2 Billion Maryland Expansion Means for the Future of Biologics Production
4
CDC’s Policy Shift on Autism and Vaccines Spurs Biopharma Quality/System Concerns
5
